Oral regimen ‘delays onset of MS’
Oral regimen ‘delays onset of MS’
For the first time, an oral therapy has been proven to reduce the risk of developing clinically definite multiple sclerosis in patients with a clinically isolated syndrome. In a phase III trial published in the journal Lancet Neurology, Miller et al clarified the role of teriflunomide (Aubagio) in the treatment of early episodes of demyelinating symptoms suggestive of MS...... Read More - http://www.ms-uk.org/aubagio
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 761 Views
-
Last post by NHE
-
- 0 Replies
- 2161 Views
-
Last post by frodo
-
- 0 Replies
- 1036 Views
-
Last post by NHE
-
- 0 Replies
- 1259 Views
-
Last post by frodo
-
- 1 Replies
- 977 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1410 Views
-
Last post by NHE
-
- 0 Replies
- 1991 Views
-
Last post by vesta
-
- 1 Replies
- 1058 Views
-
Last post by Petr75